Senzime AB (publ) (STO: SEZI)
Sweden
· Delayed Price · Currency is SEK 5.80
+0.13 (2.29%)
Dec 20, 2024, 4:51 PM CET
Senzime AB Revenue
Senzime AB had revenue of 17.41M SEK in the quarter ending September 30, 2024, with 90.15% growth. This brings the company's revenue in the last twelve months to 55.29M, up 87.73% year-over-year. In the year 2023, Senzime AB had annual revenue of 35.75M with 154.77% growth.
Revenue (ttm)
55.29M
Revenue Growth
+87.73%
P/S Ratio
12.62
Revenue / Employee
1.06M
Employees
52
Market Cap
768.35M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 35.75M | 21.72M | 154.77% |
| Dec 31, 2022 | 14.03M | 3.05M | 27.81% |
| Dec 31, 2021 | 10.98M | 1.64M | 17.60% |
| Dec 31, 2020 | 9.34M | 2.63M | 39.13% |
| Dec 31, 2019 | 6.71M | 3.50M | 108.81% |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
| Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| AstraZeneca PLC | 519.35B |
| Swedish Orphan Biovitrum AB (publ) | 25.44B |
| Sectra AB (publ) | 3.14B |
| Getinge AB (publ) | 33.59B |
| Camurus AB (publ) | 1.69B |
| Medicover AB (publ) | 22.60B |
| Vitrolife AB (publ) | 3.56B |
| Bonesupport Holding AB (publ) | 814.46M |
Senzime AB News
- 6 weeks ago - Senzime AB (SNZZF) Q3 2024 Earnings Call Highlights: Record Sales Growth and Strategic Market ... - GuruFocus
- 6 weeks ago - Q3 2024 Senzime AB (publ) Earnings Call Transcript - GuruFocus
- 6 weeks ago - Interim Report January - September 2024: Strong Sales Growth Driven by Accelerated Sensor Sales - Accesswire
- 7 weeks ago - New Number of Shares and Votes in Senzime AB (publ) - Accesswire
- 7 weeks ago - Invitation to Presentation of Senzime's Third Quarter 2024 Report - Accesswire
- 7 weeks ago - Senzime Successfully Unveils Next-Generation TetraGraph® Quantitative Train-of-Four Monitor at ANESTHESIOLOGY® 2024; U.S. Shipments Begin Q4 2024 - PRNewsWire
- 2 months ago - Bulletin From Extraordinary General Meeting in Senzime AB (publ) - Accesswire
- 2 months ago - Senzime Secures First European Hospital Order for its New Next-Generation TetraGraph System - Accesswire